Pharma tariff row: Common ailment, uncommon prescription Fortune IndiaSandoz in Talks With U.S. Government About Potential Investment, CEO Says WSJUS generics tariffs more negotiation tactic than real threat: Biocon’s Kiran Mazumdar-Shaw livemint.comPower, politics and pharma Express PharmaJuly Update — U.S. Generic Drug Tariffs: Implications For Pharma And Outsourcing Clinical Leader
